Tissue Micro Arrays are ideally suited for further validation of data regarding individual genes with a particular clinical relevance detected by cDNA array analysis.
TriStar’s high density Multi-Tumor arrays comprise over 3000 individual donor samples from over 120 different cancers. These unique arrays enable rapid evaluation of molecular targets and form the basis for further cancer-specific prognosis studies.
TriStar prognosis arrays comprise 300 – 2500 donor samples per tumor type. Outcome data appended includes tumor-specific and raw survival, treatment information and response (not from clinical trials).